Use access key #2 to skip to page content.
$4.01 0.39 (10.77%)
10/10/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

1

Avatar whodey007 (57.95) Submitted: 1/12/07 6:05 PM : Outperform Start Price: $10.13 EXEL Score: -22.27

It's only a matter of time before this stock takes off!

Report this Post Replies: 0 | Reply

Featured Broker Partners